Jul 30, 2018

Tegaderm 35 to Know: Alicia Lizzi, RN

Posted by:

Alicia Lizzi, RN, Coordinator, Infection Control Committee, Capital Federal, Buenos Aires, Argentina

Many clinicians, thought leaders and brand champions have made positive impacts in the areas of IV and wound care. In honor of the 35th anniversary of the Tegaderm™ brand, 3M recognizes 35 of these individuals who have positively impacted patient care. Alicia Lizzi, RN, from Argentina received this honor for her efforts in infection reduction.

When Lizzi entered the nursing field 35 years ago, infection prevention was not a specialty that had been explored in Argentina. Since then, she has elevated the topic through the two infection control organizations she founded.

“I’m thankful for my infection prevention colleagues who never put a ceiling on progress and professional development,” said Lizzi.

She has also served on an advisory committee that brought together more than 100 hospitals across the country to address infection reduction. Beyond leadership roles, Lizzi helps educate and train young professionals in the infection prevention field.

Lizzi has also authored many pieces on the topic of vascular access across Argentina. Check out her most recent publications:

  • Jokić, R. CVC Care and Maintenance After Insertion. Received first prize at the WoCoVA 2016 Film Festival. 2016; Lisbon.
  • Jokić, R., Lipovšek, B. Toksična epidermalna nekroliza, zdravljenje in oskrba ran v kirurški intenzivni terapiji: prispevek na konferenci – Zbornik predavanj strokovnega srečanja. 2010; 117-124.
Jul 27, 2018

Tegaderm 35 to Know: Agnieszka Kopiczko, RN

Posted by:

Agnieszka Kopiczko, RN, Gdansk, Pomerania Voyevodship, Poland

In honor of the 35th anniversary of the Tegaderm™ brand, 3M is celebrating 35 clinicians, thought leaders and pioneers who have positively impacted patient outcomes around the world. We’re calling them the Tegaderm™ Brand 35 to Know

This week, we recognize Agnieszka Kopiczko, RN, for her efforts to seek out and lead important initiatives to improve patient safety and outcomes in the IV care space.

Kopiczko is a registered nurse from Poland with more than 24 years of clinical expertise. She led a charge to update her clinic’s protocols around the insertion and maintenance of central venous catheters after she discovered a sudden and rapid increase of Catheter-Related Bloodstream Infections (CRBSIs) among bone marrow transplant patients at her clinic. This initiative has resulted in a 38 percent reduction in CRBSI rates and a 100 percent reduction in skin injuries at insertion sites.

To learn more about how you can prevent bloodstream infections, visit 3M.com/IVProtect.

Jun 28, 2018

3M Science at APIC 2018

Posted by:

3M Science at APIC 2018The biggest infection prevention conference of the year, the 45th APIC Annual Conference, was held last week right in 3M’s backyard of Minneapolis, Minnesota. We were excited to be part of the movement to advance the infection prevention efforts of facilities across the country and to help clinicians move toward reducing rates of preventable infections.

Breakfast Symposium: Reducing the Risks of CLABSI and SSI

On Friday morning, 160 APIC attendees gathered for a symposium on “Reducing the Risks of CLABSI and SSI: What Is the Evidence?” Mark Rupp, M.D., professor and chief of the division of Infectious Diseases and director of Infection Control & Epidemiology at the University of Nebraska Medical Center, shared his expertise on evidence-based measures to prevent CLABSI/CRBSI. Peggy Prinz Luebbert, MS, CLS, CIC, CHSP, CSPDT, addressed interventions in preparing patients for surgery that help reduce the risk of SSI.

IP Survey: Human Factors and the Future of Infection Prevention

3M also highlighted the results from a survey of clinicians and infection preventionists (IPs), “Human Factors and the Future of Infection Prevention,” which uncovered the key challenges they face in their fight to reduce infections in their facilities.

The survey uncovered barriers that impact successful infection prevention, including a lack of adopting new technology and processes (51%), lack of senior leadership support (51%) and poor protocol compliance (50%). However, many IPs (45%) agree that their facility could prevent more infections with more high-quality data and tools. One-third of clinicians believe infections can be avoided entirely when providing care to patients.

We want to continue this conversation and find more ways to support clinicians in their fight against healthcare associated infections. Please join us July 11 for the first in a series of webinars to discuss the IP survey results.

Both the symposium and survey results emphasized the importance of preventing infections using a three-pronged approach: developing highly trained and committed people, incorporating industry standards and implementing evidence-based technology and we were excited to showcase some of our newest offerings that help clinicians in the fight to zero infections.

If you didn’t make it to the 3M booth at APIC 2018, here are some of the new product highlights:

3M™ Tegaderm™ Antimicrobial IV Advanced Securement Dressing

To better combat bloodstream infections, specifically peripheral line associated bloodstream infections (PLABSI), we introduced a new dressing to expand the 3M antimicrobial product offerings. The new dressing integrates 2% chlorhexidine gluconate (CHG) throughout the adhesive to suppress skin flora regrowth on prepped skin for up to 7 days, which can offer another line of defense against contamination. It also provides site visibility, catheter securement and is designed for consistent application. A non-bordered version of the dressing called Tegaderm Antimicrobial Transparent Dressing will also be available.

3M™ Skin and Nasal Antiseptic

Studies show that  approximately 30 percent of the population are colonized with Staphylococcus aureus (S. aureus), the leading cause of surgical site infections (SSIs). And, more than 80 percent of surgical site infections from S. aureus come from the patient’s own nasal flora. To combat this issue, 3M’s Skin and Nasal Antiseptic provides clinicians a simple, one-time application that reduces nasal bacteria, including S. aureus and MRSA, by 99.5 percent in just one hour and maintains this reduction for at least 12 hours. 3M’s nasal antiseptic is the only one supported by more than ten investigator-initiated clinical studies showing a reduction to the risk of SSIs.

3M™ Single-Patient Stethoscope

Leading healthcare organizations recommend using a single-patient stethoscope in isolation care settings, but the single-use stethoscopes on the market often fall short in terms of durability, sound quality and comfort. The new 3M stethoscope helps reduce the risk of cross-contamination  in isolation environments by providing clinicians a high-quality, disposable stethoscope that combines excellent sound quality and comfort to help eliminate the need to use personal stethoscopes.

3M™ Bair Hugger™ Temperature Monitoring System

Core body temperature is a vital indicator of health or illness of the acute care patient. For surgical patients, a small drop in core body temperature drop can result in unintended hypothermia (a temperature below 36.0°C), which can contribute to a number ofpreventable surgical complications. The 3M Bair Hugger™ Temperature Monitoring System is a non-invasive, consistent and easy-to-use system that accurately and continuously measures the patient’s core body temperature throughout the entire perioperative journey,  helpingclinicians proactively own the normothermic temperature zone and improve patient outcomes.

3M™ Attest™ Super Rapid Biological Indicator (BI) System for Steam and 3M™ Attest™ Auto-reader 490 and 490H units

Sterile processing professionals work to clean, disinfect, and sterilize all of the instruments that allow the perioperative staff to enter surgery prepared with the tools of their trade. 3M offers sterilization assurance solutions and expertise so the sterile processing department and your OR staff know surgical instruments are safe for patient use. Our new Attest™ Dual Auto-reader technology allows facilities to incubate both steam and Hydrogen peroxide BIs in the same auto-reader with fast 24-minute results – and is available via a free software upgrade to qualified hardware. Simplify, standardize and streamline Sterile Processing Department workflows with 3M innovation and expertise.

Jun 25, 2018

3M™ Tegaderm™ Brand 35 to Know: Mary Duncan

Posted by:

Mary Duncan, RN, MSN, CICIn honor of the 35th anniversary of the Tegaderm™ brand, 3M is celebrating 35 clinicians, thought leaders and pioneers who have positively impacted patient outcomes around the world. We’re calling them the Tegaderm™ Brand 35 to Know.

This week, we recognize Mary Duncan, RN, MSN, CIC, for leading initiatives to improve patient safety and outcomes in vascular access.

Duncan is an infection prevention expert and change agent who employs innovative approaches to dramatically decrease central-line associated bloodstream infections (CLABSIs) in the facilities where she has worked.

Duncan recently conducted a study regarding the creation of a peripheral IV maintenance bundle. After the care bundle was rolled out at one facility, Duncan’s team achieved amazing results — reducing peripheral IV complications by 80 percent.

In addition to her success in infection reduction, Duncan has been actively involved in emergency management, co-chairing an influenza taskforce during the H1N1 outbreak and participating in a multi-disciplinary team to manage patients during the Ebola outbreak.

According to Duncan, the importance of education, identification of appropriate personal protective equipment and vaccination prioritization pushed infection prevention to the forefront of disaster preparation and management.

As a respected thought leader, Duncan has participated on several national infection reduction committees and developed recommendations for a prestigious report.

To learn more about how you can prevent bloodstream infections, visit 3M.com/IVProtect.

Jun 12, 2018

New survey finds infection preventionists want updated technology and processes to help fight HAI

Posted by:

Human Factors and the Future of Infection Prevention InfographicA recent survey of infection preventionists found that half (51 percent) believe lack of adopting new technology and processes and insufficient support from senior leadership are the top barriers to preventing healthcare-associated infections (HAI), followed closely by poor protocol compliance rates.

Despite the barriers, clinicians surveyed were optimistic about their ability to improve infection rates. One-third believed infections can be avoided when providing healthcare. Survey data also indicated these clinicians are seeking technological advances that will help them reduce preventable infections.

The survey, Human Factors and the Future of Infection Prevention, was commissioned by 3M and conducted by a third-party research firm in April 2018. Of the 650 completed interviews, 237 respondents identified themselves as infection preventionists. The remaining respondents were predominately nurses with patient care responsibilities.

“At 3M, we are on a mission to partner with clinicians to take on preventable infections,” Pat Parks, MD, PhD, Medical Director, 3M Medical Solutions Division stated in a press release issued earlier this week. “We wanted to gain a better understanding of beliefs and perceptions clinicians hold about the current reality and future potential of infection prevention. Armed with these insights, we’re convening with critical stakeholders to support clinicians in their fight against HAIs.”

Based on the survey data, 3M will be hosting a series of events focused on advancing infection prevention, starting with a webinar on July 11, 2018, to discuss in more depth the barriers to infection prevention revealed in the survey. Register at 3M.com/IPSurveyWebinar.

Upcoming events will reveal survey findings on clinicians’ attitudes and beliefs about infection prevention trends, best practices, compliance, auditing, and training.

Stay tuned for the full survey results – including insights on fighting both peripheral (PLABSI) and central line-associated bloodstream infections (CLABSI) and surgical site infections (SSI) – to be published later this year.